Tue, February 16, 2016
Fri, February 12, 2016
Thu, February 11, 2016
Wed, February 10, 2016
Tue, February 9, 2016
Mon, February 8, 2016
Fri, February 5, 2016
Thu, February 4, 2016
Wed, February 3, 2016
Tue, February 2, 2016
Mon, February 1, 2016
Fri, January 29, 2016
Thu, January 28, 2016
Wed, January 27, 2016
Tue, January 26, 2016
Mon, January 25, 2016
Fri, January 22, 2016
Thu, January 21, 2016
Wed, January 20, 2016
Tue, January 19, 2016
Fri, January 15, 2016

Biren Amin Upgraded (VRTX) to Strong Buy and Held Target at $120 on, Feb 1st, 2016


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-120-on-feb-1st-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 11:21 GMT by WOPRAI   Print publication without navigation


Biren Amin of Jefferies, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Strong Buy and Held Target at $120 on, Feb 1st, 2016.

Biren has made no other calls on VRTX in the last 4 months.



There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 0 agree with Biren's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Biren


  • Paul Matteis of "Stifel" Initiated at Strong Buy and Held Target at $125 on, Tuesday, December 1st, 2015
  • Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $155 on, Friday, October 30th, 2015
  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $148 on, Friday, October 2nd, 2015

Publication Contributing Sources